摘要
口服缓控释制剂在胃肠道中停留转运的时间显著长于普通制剂,更易受胃肠道生理因素的影响。因此,研究和建立与体内相关的体外释放评价方法,对于保证口服缓控释制剂的内在质量非常重要。文中从装置、释放介质pH、表面活性剂、食物、乙醇等方面综述了近几年口服缓控释制剂体外释放的最新进展。
Since the oral sustained-release systems stay in the gastrointestinal tract (GIT) much longer, the drug release from the oral sustained-release systems is influenced easier by the physiological conditions of the GIT than that from the conventional preparations. For the quality control of the oral sustained-release systems, it is very important to study and establish in vitro release methods with a good in vivo and in vitro correlation. Based on relevant literature, improvements on the release conditions such as release apparatus, the pH value of release medi- um, surfactant, food and alcohol for in vitro release of oral sustained-release systems were reviewed.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2013年第2期196-200,共5页
Chinese Journal of New Drugs
基金
国家"重大新药创制"科技重大专项(2008ZXJ09010-001
2009ZX09301-002)
关键词
口服
缓控释制剂
体外释放
体内外相关性
释放装置
释放介质
oral
sustained-release systems
in vitro release
in vivo/in vitro correlation
release appara- tus
release medium